
Rei Tsang Shiao
Examiner (ID: 13461, Phone: (571)272-0707 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1626, 1628, 1629, 1691 |
| Total Applications | 3000 |
| Issued Applications | 2172 |
| Pending Applications | 215 |
| Abandoned Applications | 676 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9615737
[patent_doc_number] => 20140205595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'COMPOUNDS AND METHODS OF PROPHYLAXIS AND TREATMENT REGARDING NICOTINIC RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 14/127699
[patent_app_country] => US
[patent_app_date] => 2012-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8263
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14127699
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/127699 | Compounds and methods of prophylaxis and treatment regarding nicotinic receptor antagonists | Jun 21, 2012 | Issued |
Array
(
[id] => 9615739
[patent_doc_number] => 20140205596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'ORGANIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/128378
[patent_app_country] => US
[patent_app_date] => 2012-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11519
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14128378
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/128378 | Organic compounds | Jun 21, 2012 | Issued |
Array
(
[id] => 9450011
[patent_doc_number] => 20140121181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'HYDROPHOBIC POLYMER COMPOUND HAVING ANTICOAGULANT EFFECT'
[patent_app_type] => utility
[patent_app_number] => 14/127046
[patent_app_country] => US
[patent_app_date] => 2012-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7852
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14127046
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/127046 | HYDROPHOBIC POLYMER COMPOUND HAVING ANTICOAGULANT EFFECT | Jun 21, 2012 | Abandoned |
Array
(
[id] => 8442514
[patent_doc_number] => 20120259130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'PROCESS FOR SYNTHESIZING PHOSPHONIC AND PHOSPHINIC ACID COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/526995
[patent_app_country] => US
[patent_app_date] => 2012-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14550
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13526995
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/526995 | PROCESS FOR SYNTHESIZING PHOSPHONIC AND PHOSPHINIC ACID COMPOUNDS | Jun 18, 2012 | Abandoned |
Array
(
[id] => 9436027
[patent_doc_number] => 20140113934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-24
[patent_title] => 'HETEROCYCLIC COMPOUNDS FOR TREATING HELMINTH INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 14/124730
[patent_app_country] => US
[patent_app_date] => 2012-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31188
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14124730
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/124730 | HETEROCYCLIC COMPOUNDS FOR TREATING HELMINTH INFECTIONS | Jun 18, 2012 | Abandoned |
Array
(
[id] => 8430961
[patent_doc_number] => 20120252836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => '1,3-Dioxanes and Their Uses'
[patent_app_type] => utility
[patent_app_number] => 13/526110
[patent_app_country] => US
[patent_app_date] => 2012-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18504
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13526110
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/526110 | 1,3-Dioxanes and Their Uses | Jun 17, 2012 | Abandoned |
Array
(
[id] => 9813099
[patent_doc_number] => 20150025043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'ORAL FORMULATIONS OF MITOCHONDRIALLY-TARGETED ANTIOXIDANTS AND THEIR PREPARATION AND USE'
[patent_app_type] => utility
[patent_app_number] => 14/123311
[patent_app_country] => US
[patent_app_date] => 2012-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10097
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14123311
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/123311 | Oral formulations of mitochondrially-targeted antioxidants and their preparation and use | Jun 3, 2012 | Issued |
Array
(
[id] => 10514904
[patent_doc_number] => 09241936
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-26
[patent_title] => 'Use of rupatadine in the manufacture of pharmaceutical composition for treating chronic obstructive pulmonary disease'
[patent_app_type] => utility
[patent_app_number] => 14/383459
[patent_app_country] => US
[patent_app_date] => 2012-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 4613
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14383459
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/383459 | Use of rupatadine in the manufacture of pharmaceutical composition for treating chronic obstructive pulmonary disease | May 17, 2012 | Issued |
Array
(
[id] => 9422460
[patent_doc_number] => 20140107111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'USE OF SIGMA LIGANDS IN DIABETES TYPE-2 ASSOCIATED PAIN'
[patent_app_type] => utility
[patent_app_number] => 14/118704
[patent_app_country] => US
[patent_app_date] => 2012-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10681
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14118704
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/118704 | Use of sigma ligands in diabetes type-2 associated pain | May 17, 2012 | Issued |
Array
(
[id] => 8381490
[patent_doc_number] => 20120225116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => 'BIODEGRADABLE POLYPHOSPHAZENES CONTAINING PYRROLIDONE SIDE GROUPS'
[patent_app_type] => utility
[patent_app_number] => 13/470453
[patent_app_country] => US
[patent_app_date] => 2012-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4172
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13470453
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/470453 | BIODEGRADABLE POLYPHOSPHAZENES CONTAINING PYRROLIDONE SIDE GROUPS | May 13, 2012 | Abandoned |
Array
(
[id] => 9245576
[patent_doc_number] => 08609857
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-17
[patent_title] => 'Poly(ethylene glycol) containing chemically disparate endgroups'
[patent_app_type] => utility
[patent_app_number] => 13/471064
[patent_app_country] => US
[patent_app_date] => 2012-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28247
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13471064
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/471064 | Poly(ethylene glycol) containing chemically disparate endgroups | May 13, 2012 | Issued |
Array
(
[id] => 9806434
[patent_doc_number] => 20150018379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'Intranasal Pharmaceutical Dosage Forms Comprising Naloxone'
[patent_app_type] => utility
[patent_app_number] => 14/084551
[patent_app_country] => US
[patent_app_date] => 2012-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 15770
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14084551
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/084551 | Intranasal Pharmaceutical Dosage Forms Comprising Naloxone | May 10, 2012 | Abandoned |
Array
(
[id] => 10831364
[patent_doc_number] => 08859533
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-14
[patent_title] => 'Metalloinsertor complexes targeted to DNA mismatches'
[patent_app_type] => utility
[patent_app_number] => 13/511642
[patent_app_country] => US
[patent_app_date] => 2012-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 81
[patent_no_of_words] => 15170
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511642
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/511642 | Metalloinsertor complexes targeted to DNA mismatches | May 9, 2012 | Issued |
Array
(
[id] => 8995285
[patent_doc_number] => 08519170
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-27
[patent_title] => 'Compounds for preparing immunological adjuvant'
[patent_app_type] => utility
[patent_app_number] => 13/468634
[patent_app_country] => US
[patent_app_date] => 2012-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20451
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13468634
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/468634 | Compounds for preparing immunological adjuvant | May 9, 2012 | Issued |
Array
(
[id] => 8371250
[patent_doc_number] => 20120220643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'Amino Acid Compounds'
[patent_app_type] => utility
[patent_app_number] => 13/468231
[patent_app_country] => US
[patent_app_date] => 2012-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8771
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13468231
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/468231 | Amino acid compounds | May 9, 2012 | Issued |
Array
(
[id] => 8721256
[patent_doc_number] => 20130072473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'COMPOUNDS FOR TREATING PROTEIN FOLDING DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/467949
[patent_app_country] => US
[patent_app_date] => 2012-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 38834
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13467949
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/467949 | COMPOUNDS FOR TREATING PROTEIN FOLDING DISORDERS | May 8, 2012 | Abandoned |
Array
(
[id] => 8371248
[patent_doc_number] => 20120220642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'Amino Acid Compounds'
[patent_app_type] => utility
[patent_app_number] => 13/465947
[patent_app_country] => US
[patent_app_date] => 2012-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8831
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13465947
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/465947 | Amino acid compounds | May 6, 2012 | Issued |
Array
(
[id] => 9363742
[patent_doc_number] => 20140073615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-13
[patent_title] => 'Treatment of Psoriasis'
[patent_app_type] => utility
[patent_app_number] => 14/114778
[patent_app_country] => US
[patent_app_date] => 2012-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4515
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14114778
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/114778 | Treatment of Psoriasis | Apr 29, 2012 | Abandoned |
Array
(
[id] => 9435976
[patent_doc_number] => 20140113884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-24
[patent_title] => 'EPOXYEICOSATRIENOIC ACID ANALOGS AND METHODS OF MAKING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/009658
[patent_app_country] => US
[patent_app_date] => 2012-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 44079
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14009658
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/009658 | Epoxyeicosatrienoic acid analogs and methods of making and using the same | Apr 3, 2012 | Issued |
Array
(
[id] => 8431026
[patent_doc_number] => 20120252900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'GREASE-LIKE GEL FOR REPELLING INSECTS AND PREVENTING UNDESIRABLE BEHAVIOR IN HOOFED ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 13/439631
[patent_app_country] => US
[patent_app_date] => 2012-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10707
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13439631
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/439631 | Grease-like gel for repelling insects and preventing undesirable behavior in hoofed animals | Apr 3, 2012 | Issued |